T. Rowe Price Associates
OMDA

T. Rowe Price Associates’s Omada Health Inc OMDA Stock Holding History

T. Rowe Price Associates’s Portfolio OMDA Stock Details OMDA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.42M Sell
201,280
-3,132
-2% -$50K ﹤0.01% 1624
2026
Q1 		$2.57M Sell
204,412
-10,096
-5% -$139K ﹤0.01% 1720
2025
Q4 		$3.39M Buy
+214,508
New +$4.35M ﹤0.01% 1528

Other funds holding OMDA

RCM
Revelation Capital Management Sausalito, California $110M AUM
DSCM
Divisadero Street Capital Management Miami, Florida $4.41B AUM 90.53% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
CI
Cigna Investments Bloomfield, Connecticut $773M AUM 44.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
NA
NVP Associates Menlo Park, California $328M AUM 166.51% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

T. Rowe Price Associates's OMDA Position: Q2 2026 in Review

T. Rowe Price Associates reduced its Omada Health Inc (OMDA) stake by 1.5% in Q2 2026, selling an estimated $50K and leaving 201,280 shares worth $4.42M. The position accounts for ﹤0.01% of the portfolio, ranked #1624.

T. Rowe Price Associates first reported a position in OMDA in Q4 2025 and has held it in 3 quarters since. 154 funds tracked by Wall St. Rank hold OMDA as of Q2 2026.

  • T. Rowe Price Associates held 201,280 shares of Omada Health Inc worth $4.42M as of Q2 2026.
  • T. Rowe Price Associates sold 3,132 Omada Health Inc shares in Q2 2026, an estimated $50K.
  • Omada Health Inc made up ﹤0.01% of T. Rowe Price Associates's portfolio in Q2 2026, its #1624 holding.
  • T. Rowe Price Associates first reported a position in Omada Health Inc in Q4 2025 and has held it in 3 quarters since.
  • 154 funds tracked by Wall St. Rank held Omada Health Inc as of Q2 2026.

Based on T. Rowe Price Associates's 13F filing for Q2 2026, filed 14 Aug 2026.